Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced or Metastatic Solid Tumors × envafolimab × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 2 Carcinoma, Non-Small-Cell Lung 1 Advanced or Metastatic Solid Tumors 1

Interventions

Nivolumab 2 trifluridine tipiracil drug combination 1 pembrolizumab 1 envafolimab 1 cobimetinib 1 TAK-981 1 Ipilimumab 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03248843 2022-02-08

A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors

3D Medicines

Phase 1 Completed

Other solid neoplasm

Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡